all news

Fri, 5 Dec 2025 PR Newswire

Freenome and Perceptive Capital Solutions Corp Announce Business Combination Agreement to Create a Publicly Listed Company Transforming Blood-Based Multi-Cancer Detection through an AI/ML-Enabled Multiomics Platform

Wed, 3 Dec 2025 GlobeNewswire

Larkspur Biosciences Begins Dosing in Clinical Study of LRK-4189, a First-in-Class Targeted Protein Degrader

Tue, 2 Dec 2025 Business Wire

Podimetrics Unveils Provider Insights Report to Prevent Diabetic Foot Ulcers and Reduce Amputations

Fri, 21 Nov 2025 FierceBiotech

Roche inks $200M+ licensing pact for Freenome's cancer screening blood tests

Thu, 20 Nov 2025 PR Newswire

Cohere Health Ranked Among North America's Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500™

Mon, 17 Nov 2025 Associated Press

Ankyra Therapeutics Announces First Patient Dosed in Phase 1b Trial Evaluating First-in-Class Anchored Immunotherapy in Combination with Immune Checkpoint Blockade in Patients with Lung Cancer

Wed, 12 Nov 2025 BioSpace

Dyno Therapeutics and Trisk Bio Announce Strategic Manufacturing Partnership Through Expanded Frontiers Program

Mon, 10 Nov 2025 Yahoo! Finance

Muna Therapeutics Announces First Subjects Dosed in Phase 1 Trial of Novel Oral TREM2 Agonist for Early Alzheimer's Disease

Thu, 6 Nov 2025 GlobeNewswire

Noema Pharma Announces Phase 2a Study Results with Cendifensine in Women with Vasomotor Symptoms (Hot Flashes) Due to Menopause

Tue, 4 Nov 2025 Yahoo! Finance

Sovato raises Series B funds to advance remote robotic surgery platform

Wed, 29 Oct 2025 WebWire

Indomo Launches Out of Stealth with $25M to Bring Instant, At-Home Acne Injections to Consumers

Tue, 28 Oct 2025 Zag Bio

Zag Bio™ Launches with $80 Million Financing to Advance Thymus-targeted Medicines for Autoimmune Diseases | Zag Bio

Mon, 27 Oct 2025 Associated Press

Neumora Therapeutics Announces Class-Leading Weight Loss Demonstrated with NMRA-215 in Preclinical Diet-Induced Obesity Model

Tue, 21 Oct 2025 Podimetrics

Podimetrics Launches SmartMat+ to Save Limbs, Reduce Falls, and Monitor Signs of Heart Failure in Complex Diabetes.

Thu, 16 Oct 2025 Associated Press

Cohere Health Improves Provider Experience with AI-powered Ambient Prior Authorization at the Point of Care

Tue, 7 Oct 2025 GlobeNewswire

Sonrai Security Introduces WALLy: The First AI Agent That Safely Fixes Cloud Privilege Risk

Mon, 6 Oct 2025 Associated Press

Wellthy Acquires Patch Caregiving to Expand Innovative Childcare with On-Site and Near-Site Backup Care Solutions

Thu, 2 Oct 2025 GlobeNewswire

Cirrus Therapeutics Raises $11 M Seed Financing to Advance Novel Ocular Gene Therapy to Reverse Underlying Age-Related Cause of Dry AMD

Mon, 29 Sep 2025 Barchart

Faro Wins CDISC 2025 AI Innovation Challenge for Protocol Library Solution

Tue, 23 Sep 2025 Associated Press

Triveni Doses First Subject in Global Phase 2 Proof of Concept Study of TRIV-509 in Atopic Dermatitis, Presents Translational Data at 2025 EADV Congress Demonstrating Novel Biology in Patient Samples

Fri, 19 Sep 2025 Business Wire

Endpoints News Announces the 2025 Winners of the Endpoints 11 Awards, Highlighting Biotech’s Most Promising Startups

Wed, 17 Sep 2025 Associated Press

ByHeart Debuts its “Best for Breastfed Babies” Infant Formula at SamsClub.com in Exclusive 2-Pack

Wed, 17 Sep 2025 GlobeNewswire

FloQast Unveils AI Agent Builder and Expanded AI Capabilities to Redefine the Future of Accounting

Tue, 16 Sep 2025 Yahoo! Finance

Crossbow Therapeutics Doses First Patient in Phase 1 Trial of CBX-250 for Myeloid Malignancies

Thu, 11 Sep 2025 PR Newswire

Amplifire's adaptive learning platform drives transformational EHR training success at Ochsner Health

Wed, 10 Sep 2025 GlobeNewswire

Dewpoint Therapeutics Closes Series D Financing to Advance First-in-Class Condensate Modulator (c-mod) into Clinical Development for Gastric Cancer

Fri, 5 Sep 2025 GeneOnline

Remedy Meds to Acquire Thirty Madison to Expand Telehealth Services Across Multiple Health Areas

Thu, 28 Aug 2025 Clinical Lab Products

PathAI Expands FDA Clearance for AISight Dx to Support More Slide Scanners

Wed, 20 Aug 2025 GlobeNewswire

Larkspur Biosciences Announces Discovery of LRK-4189, a First-in-Class Degrader of the Lipid Kinase PIP4K2C, for the Treatment of Microsatellite Stable (MSS) Colorectal Cancer at the ACS Fall 2025 Meeting

Tue, 19 Aug 2025 Associated Press

AbbVie Completes Acquisition of Capstan Therapeutics